Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201137
Max Phase: Preclinical
Molecular Formula: C31H38N6O6S
Molecular Weight: 622.75
Associated Items:
ID: ALA5201137
Max Phase: Preclinical
Molecular Formula: C31H38N6O6S
Molecular Weight: 622.75
Associated Items:
Canonical SMILES: CNC(=O)NC1CCN(C(=O)[C@H](Cc2cccc(C(=N)N)c2)NS(=O)(=O)c2cccc(-c3ccc(OC)cc3OC)c2)CC1
Standard InChI: InChI=1S/C31H38N6O6S/c1-34-31(39)35-23-12-14-37(15-13-23)30(38)27(17-20-6-4-8-22(16-20)29(32)33)36-44(40,41)25-9-5-7-21(18-25)26-11-10-24(42-2)19-28(26)43-3/h4-11,16,18-19,23,27,36H,12-15,17H2,1-3H3,(H3,32,33)(H2,34,35,39)/t27-/m0/s1
Standard InChI Key: MAGALRRMBKHPFW-MHZLTWQESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 622.75 | Molecular Weight (Monoisotopic): 622.2574 | AlogP: 2.46 | #Rotatable Bonds: 11 |
Polar Surface Area: 175.94 | Molecular Species: BASE | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.02 | CX Basic pKa: 11.47 | CX LogP: 0.94 | CX LogD: -0.96 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.16 | Np Likeness Score: -1.02 |
1. Pilgram O, Keils A, Benary GE, Müller J, Merkl S, Ngaha S, Huber S, Chevillard F, Harbig A, Magdolen V, Heine A, Böttcher-Friebertshäuser E, Steinmetzer T.. (2022) Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors., 238 [PMID:35635944] [10.1016/j.ejmech.2022.114437] |
Source(1):